What Is a Normal Dose of Ozempic for Weight Loss?

Last reviewed: June 26, 2026

Last updated: June 26, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide, the active ingredient in Ozempic and Wegovy, follows a standardized dose escalation protocol designed to help your body adjust while maximizing weight loss results. Most patients begin at 0.25 mg weekly and progress through carefully timed increases over four months. Understanding how dosing works helps you set realistic expectations for your weight loss journey.

How Semaglutide Dosing Starts and Progresses

The standard semaglutide weight loss protocol divides treatment into four phases over 16 weeks. Week one through week four uses a 0.25 mg dose injected once weekly. Weeks five through eight increase to 0.5 mg weekly, while weeks nine through twelve jump to 1 mg weekly. The final four weeks typically reach 2.4 mg weekly, though some patients stabilize at 1 mg or 1.7 mg depending on their response and tolerance.

This gradual climb helps your body recognize and process the medication without overwhelming your system. Rapid dose increases often trigger nausea, constipation, and appetite suppression that feels too intense to manage comfortably. By spacing increases across four-week intervals, most patients experience steady weight loss while side effects remain mild to moderate and improve over time.

What Happens After Reaching Your Maintenance Dose

Once you reach a comfortable maintenance dose, that amount typically stays the same long-term. Many patients find their optimal dose somewhere between 1 mg and 2.4 mg weekly, depending on how their body responds and their weight loss goals. Your prescribing provider monitors your progress at regular check-ins and may suggest staying at your current dose if you are losing weight steadily and tolerating the medication well.

Some patients plateau in their weight loss or experience side effects that improve when they stay below the maximum 2.4 mg dose. This is completely normal and expected—reaching the highest available dose is not necessary for successful weight loss. PlexusDx providers work with you to find your individual sweet spot rather than pushing everyone toward the standard maximum.

Why Individual Dose Needs Vary Between Patients

Your genetics, metabolism, starting weight, and medical history all influence how your body responds to semaglutide. Two patients with identical BMI measurements may require different doses to achieve the same weight loss results. Factors like insulin resistance, stomach emptying speed, and your GLP-1 receptor sensitivity play invisible but crucial roles in determining your optimal dosing strategy.

The Precision Peptide Genetic Test offered by PlexusDx maps your genetic variants in key metabolic pathways, including FTO rs9939609, and MC4R rs17782313. These insights help providers understand whether you might respond strongly to lower doses or need higher amounts to feel appetite suppression. Genetic personalization removes guesswork from dose planning and often leads to faster, more comfortable weight loss.

PlexusDx Semaglutide Pricing and Dose Flexibility

PlexusDx compounded semaglutide injections are $189/mo month-to-month, or from $149/mo on the 6-month plan across all three commitment tiers, with pricing remaining flat regardless of your dose level. Whether you take 0.25 mg weekly or 2.4 mg weekly, your monthly cost stays the same—your dose may need to go up, but your price won't. This flat pricing model eliminates the cost barrier that often prevents patients from finding their true optimal dose.

PlexusDx medications come from licensed 503A compounding pharmacies and serve all 50 states without requiring insurance or membership fees. Injections are HSA and FSA eligible, making them accessible to patients managing their own healthcare costs. After your first month of treatment, you can add the Precision Peptide Genetic Test for $298 to unlock personalized dosing insights based on your unique peptide pathway genetics.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

Is the standard 16-week dose escalation mandatory, or can dosing be customized?

The 16-week protocol is standard, but PlexusDx providers can adjust the speed and final target based on your tolerance and response. Some patients move through phases more slowly to minimize nausea, while others reach their goal dose faster if they tolerate increases well. Your individual dose and timeline are determined during your initial consultation.

What clinical trial data supports the standard semaglutide dosing schedule?

The STEP trials (Semaglutide Treatment Effect in People with Obesity) established that 2.4 mg weekly produced the greatest average weight loss—around 15% of body weight over 68 weeks. However, meaningful weight loss occurred at all dose levels tested, and many patients in the trials stabilized at lower maintenance doses without losing efficacy over time. Individual response varies significantly.

How much does PlexusDx compounded semaglutide cost monthly?

PlexusDx semaglutide injections are $189/mo month-to-month, or from $149/mo on the 6-month plan and remain flat across all three commitment tiers—no flat per-compound pricing increases. All medications come from licensed 503A compounding pharmacies, require no insurance, and are HSA/FSA eligible. You can also add the Precision Peptide Genetic Test ($298).

Are side effects worse at higher semaglutide doses?

Side effects typically increase with dose but improve significantly within two to three weeks at each new dose level as your body adapts. Nausea, the most common side effect, peaks around days three to five after injection and subsides by day seven for most patients. Staying at a lower maintenance dose that works for you eliminates the need to push toward higher doses and their associated side effect risk.

How does the Precision Peptide Genetic Test help with semaglutide dosing?

No — the Precision Peptide Genetic Test does not predict your response to Ozempic or any specific medication. It analyzes pathway-level variants (GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

• Ozempic For Weight Loss 2
• Average Weight Loss On Ozempic
• Weight Loss Drugs Like Ozempic
• Ozempic Weight Loss Before And After Pictures

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.